Newsome PN - Search Results

1

Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol.

Than NN, Tomlinson CL, Haldar D, King AL, Moore D, Newsome PN. Than NN, et al. Among authors: newsome pn. Syst Rev. 2016 Jun 14;5:100. doi: 10.1186/s13643-016-0277-6. Syst Rev. 2016. PMID: 27301957 Free PMC article.

2

Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease.

Newsome PN, Beldon I, Moussa Y, Delahooke TE, Poulopoulos G, Hayes PC, Plevris JN. Newsome PN, et al. Aliment Pharmacol Ther. 2000 Oct;14(10):1295-301. doi: 10.1046/j.1365-2036.2000.00849.x. Aliment Pharmacol Ther. 2000. PMID: 11012474 Free article.

3

Emerging drugs for complications of end-stage liver disease.

Dowman JK, Holt AP, Newsome PN, Adams DH. Dowman JK, et al. Among authors: newsome pn. Expert Opin Emerg Drugs. 2008 Mar;13(1):159-74. doi: 10.1517/14728214.13.1.159. Expert Opin Emerg Drugs. 2008. PMID: 18321155 Review.

4

Critical review of clinical trials of bone marrow stem cells in liver disease.

Houlihan DD, Newsome PN. Houlihan DD, et al. Among authors: newsome pn. Gastroenterology. 2008 Aug;135(2):438-50. doi: 10.1053/j.gastro.2008.05.040. Epub 2008 May 15. Gastroenterology. 2008. PMID: 18585384 Review.

5

Non-enzymatic dissociation of human mesenchymal stromal cells improves chemokine-dependent migration and maintains immunosuppressive function.

Garg A, Houlihan DD, Aldridge V, Suresh S, Li KK, King AL, Sutaria R, Fear J, Bhogal RH, Lalor PF, Newsome PN. Garg A, et al. Among authors: newsome pn. Cytotherapy. 2014 Apr;16(4):545-59. doi: 10.1016/j.jcyt.2013.10.003. Cytotherapy. 2014. PMID: 24629709

6

Bone marrow stem cell therapy for liver disease.

King A, Newsome PN. King A, et al. Among authors: newsome pn. Dig Dis. 2014;32(5):494-501. doi: 10.1159/000360491. Epub 2014 Jul 14. Dig Dis. 2014. PMID: 25034281 Review.

7

A concise review of non-alcoholic fatty liver disease.

Than NN, Newsome PN. Than NN, et al. Among authors: newsome pn. Atherosclerosis. 2015 Mar;239(1):192-202. doi: 10.1016/j.atherosclerosis.2015.01.001. Epub 2015 Jan 13. Atherosclerosis. 2015. PMID: 25617860 Review.

8

Non-alcoholic fatty liver disease: when to intervene and with what.

Than NN, Newsome PN. Than NN, et al. Among authors: newsome pn. Clin Med (Lond). 2015 Apr;15(2):186-90. doi: 10.7861/clinmedicine.15-2-186. Clin Med (Lond). 2015. PMID: 25824073 Free PMC article.

9

CD248/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanism.

Wilhelm A, Aldridge V, Haldar D, Naylor AJ, Weston CJ, Hedegaard D, Garg A, Fear J, Reynolds GM, Croft AP, Henderson NC, Buckley CD, Newsome PN. Wilhelm A, et al. Among authors: newsome pn. Gut. 2016 Jul;65(7):1175-85. doi: 10.1136/gutjnl-2014-308325. Epub 2015 Jun 15. Gut. 2016. PMID: 26078290 Free PMC article.

10

Hepatocyte cell therapy in liver disease.

Bartlett DC, Newsome PN. Bartlett DC, et al. Among authors: newsome pn. Expert Rev Gastroenterol Hepatol. 2015;9(10):1261-72. doi: 10.1586/17474124.2015.1073106. Epub 2015 Jul 27. Expert Rev Gastroenterol Hepatol. 2015. PMID: 26212798 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

219 results

Search Page